• 1
    Schneider, R.K., Bramlage, L.R., Moore, R.M., Mecklenburg, L.M., Kohn, C.W. and Gabel, A.A. (1992) A retrospective study of 192 horses affected with septic arthritis/tenosynovitis. Equine Vet. J. 24, 436-442.
  • 2
    Smith, L.J., Marr, C.M., Payne, R.J., Stoneham, S.J. and Reid, S.W.J. (2004) What is the likelihood that Thoroughbred foals treated for septic arthritis will race? Equine Vet. J. 36, 452-456.
  • 3
    Neil, K., Axon, J., Begg, A., Todhunter, P., Adams, P., Fine, A., Caron, J. and Adkins, A. (2010) Retrospective study of 108 foals with septic osteomyelitis. Aust. Vet. J. 88, 4-12.
  • 4
    Taintor, J., Schumacher, J. and Degraves, F. (2006) Comparison of amikacin concentrations in normal and inflamed joints of horses following intra-articular administration. Equine Vet. J. 38, 189-191.
  • 5
    Schneider, R.K. (1998) Common bacteria encountered in septic arthritis. Proc. Am. Ass. Equine Practnrs. 44, 152-158.
  • 6
    Madison, J., Sommer, M. and Spencer, P. (1991) Relations among synovial membrane histopathologic findings, synovial fluid cytologic findings, and bacterial culture results in horses with suspected infectious arthritis: 64 cases (1979-1987). J. Am. Vet. Med. Ass. 198, 1655-1661.
  • 7
    Walmsley, E., Anderson, G., Muurlink, M. and Whitton, R. (2011) Retrospective investigation of prognostic indicators for adult horses with infection of a synovial structure. Aust. Vet. J. 89, 226-231.
  • 8
    Van Pelt, R.W. (1974) Interpretation of synovial fluid findings in the horse. J. Am. Vet. Med. Ass. 165, 91-95.
  • 9
    Bertone, A.L., Palmer, J.L. and Jones, J. (2001) Synovial fluid cytokines and eicosanoids as markers of joint disease in horses. Vet. Surg. 30, 528-538.
  • 10
    Gibson, K.T., McIlwraith, C.W., Turner, A.S., Stashak, T.S., Aanes, W.A. and Trotter, G.W. (1989) Open joint injuries in horses: 58 cases (1980-1986). J. Am. Vet. Med. Ass. 194, 398-404.
  • 11
    Gibson, K.T., Hodge, H. and Whittem, T. (1996) Inflammatory mediators in equine synovial fluid. Aust. Vet. J. 73, 148-151.
  • 12
    Korenek, N.L., Andrews, F.M., Maddux, J.M., Sanders, W.L. and Faulk, D.L. (1992) Determination of total protein concentration and viscosity of synovial fluid from the tibiotarsal joints of horses. Am. J. Vet. Res. 53, 781-784.
  • 13
    Lugo, J. and Gaughan, E.M. (2006) Septic arthritis, tenosynovitis, and infections of hoof structures. Vet. Clin. N. Am.: Equine Pract 22, 363-388.
  • 14
    Bertone, A.L. (1996) Infectious arthritis. In: Joint Disease in the Horse, Eds: C.W. McIlwraith, G.W. Trotter and W.B. Saunders, Saunders, Elsevier, Philadelphia. pp 397-409.
  • 15
    Frisbie, D.D. (2006) Synovial joint biology and pathobiology. In: Equine Surgery, 3rd edn., Eds: J.A. Auer and J.A. Stick, Elsevier Inc., St. Louis. pp 1036-1055.
  • 16
    Steel, C.M. (2008) Equine synovial fluid analysis. Vet. Clin. N. Am.: Equine Pract 24, 437-454.
  • 17
    Jacobsen, S., Thomsen, M.H. and Nanni, S. (2006) Concentrations of serum amyloid A in serum and synovial fluid from healthy horses and horses with joint disease. Am. J. Vet. Res. 67, 1738-1742.
  • 18
    Dykraaf, S., Dechant, J.E., Johns, J.L., Christopher, M.M., Bolt, D.M. and Snyder, J.R. (2007) Effect of intrathecal amikacin administration and repeated centesis on digital flexor tendon sheath synovial fluid in horses. Vet. Surg. 36, 57-63.
  • 19
    Hultén, C., Sletten, K., Foyn Bruun, C. and Marhaug, G. (1997) The acute phase serum amyloid A protein (SAA) in the horse: isolation and characterization of three isoforms. Vet. Immunol. Immunopathol. 57, 215-227.
  • 20
    Jacobsen, S., Nielsen, J.V., Kjelgaard-Hansen, M., Toelboell, T., Fjeldborg, J., Halling-Thomsen, M., Martinussen, T. and Thoefner, M.B. (2009) Acute phase response to surgery of varying intensity in horses: a preliminary study. Vet. Surg. 38, 762-769.
  • 21
    Nunokawa, Y., Fujinaga, T., Taira, T., Okumura, M., Yamashita, K., Tsunoda, N. and Hagio, M. (1993) Evaluation of serum amyloid A protein as an acute-phase reactive protein in horses. J. Vet. Med. Sci. 55, 1011-1016.
  • 22
    Pepys, M.B., Baltz, M.L., Tennent, G.A., Kent, J., Ousey, J. and Rossdale, P.D. (1989) Serum amyloid A protein (SAA) in horses: objective measurement of the acute phase response. Equine Vet. J. 21, 106-109.
  • 23
    Husebekk, A., Husby, G., Sletten, K., Marhaug, G. and Nordstoga, K. (1986) Characterization of amyloid protein AA and its serum precursor SAA in the horse. Scand. J. Immunol. 23, 703-709.
  • 24
    Jacobsen, S., Niewold, T.A., Halling-Thomsen, M., Nanni, S., Olsen, E., Lindegaard, C. and Andersen, P.H. (2006) Serum amyloid A isoforms in serum and synovial fluid in horses with lipopolysaccharide-induced arthritis. Vet. Immunol. Immunopathol. 110, 325-330.
  • 25
    Bassage, L.H., II and Ross, M.W. (2011) Diagnostic analgesia. In: Diagnosis and Management of Lameness in the Horse, 2nd edn., Eds: M.W. Ross and S.J. Dyson, Elsevier Inc., St. Louis, Missouri. pp 100-135.
  • 26
    Ross, M.W. and Dyson, S.J. (2011) Chapter 7: movement. In: Diagnosis and Management of Lameness in the Horse, 2nd edn., Eds: M.W. Ross and S.J. Dyson, Elsevier Inc., St. Louis, Missouri. pp 64-80.
  • 27
    Jacobsen, S., Kjelgaard-Hansen, M., Hagbard Petersen, H. and Jensen, A.L. (2006) Evaluation of a commercially available human serum amyloid A (SAA) turbidometric immunoassay for determination of equine SAA concentrations. Vet. J. 172, 315-319.
  • 28
    Matthews, J.N., Altman, D.G., Campbell, M.J. and Royston, P. (1990) Analysis of serial measurements in medical research. Br. Med. J. 300, 230-235.
  • 29
    Itoh, K., Sasaki, Y., Fujii, H., Minami, H., Ohtsu, T., Wakita, H., Igarashi, T., Watanabe, Y., Onozawa, Y., Kashimura, M. and Ohashi, Y. (2000) Study of dose escalation and sequence switching of administration of the combination of docetaxel and doxorubicin in advanced breast cancer. Clin. Cancer Res. 6, 4082-4090.
  • 30
    Moyer, W., Schumacher, J. and Schumacher, J. (2007) A Guide to Equine Joint Injection and Regional Anesthesia. MediMedia USA, USA. pp 109.
  • 31
    Malle, E. and De Beer, F.C. (1996) Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur. J. Clin. Invest. 26, 427-435.
  • 32
    Hoffman, J.S. and Benditt, E.P. (1983) Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance. J. Clin. Invest. 71, 926-934.
  • 33
    Bolt, D.M., Ishihara, A., Weisbrode, S.E. and Bertone, A.L. (2008) Effects of triamcinolone acetonide, sodium hyaluronate, amikacin sulfate, and mepivacaine hydrochloride, alone and in combination, on morphology and matrix composition of lipopolysaccharide-challenged and unchallenged equine articular cartilage explants. Am. J. Vet. Res. 69, 861-867.
  • 34
    Jacobsen, S. and Andersen, P.H. (2007) The acute phase protein serum amyloid A (SAA) as a marker of inflammation in horses. Equine. Vet. Educ. 19, 38-46.